Nanoparticle Tri-adjuvant

Nanoparticle Tri-adjuvant is a three-component nanocage vaccine adjuvant that integrates 3-O-desacyl-4'-monophosphoryl lipid A (a TLR4 agonist) with the saponins QS-21 and QS-7 into a roughly 40 nm cage-like nanostructure via molecular self-assembly, intended to drive strong dual-pathway cellular immunity and high neutralizing antibody levels while QS-7 moderates the inflammatory response otherwise triggered by QS-21 alone. Manufactured directly by Chengdu GC Biotech Co., Ltd. at pharmaceutical grade and certified to ChP, USP, EP and in-house standards, it is supplied in 5 mL and 500 mL specifications and sold into North America, Central/South America, Western Europe, Australasia, Asia and the Middle East.